These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9873506

  • 21. Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists.
    Wallis RM.
    Life Sci; 1995; 56(11-12):861-8. PubMed ID: 10188786
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivatives.
    Mitsuya M, Ogino Y, Kawakami K, Uchiyama M, Kimura T, Numazawa T, Hasegawa T, Ohtake N, Noguchi K, Mase T.
    Bioorg Med Chem; 2000 Apr; 8(4):825-32. PubMed ID: 10819171
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists.
    Wang Y, Chackalamannil S, Hu Z, Greenlee WJ, Clader J, Boyle CD, Kaminski JJ, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, Cohen-Williams M, Coffin VL, Cox KA, Grotz DE, Lachowicz JE.
    J Med Chem; 2002 Dec 05; 45(25):5415-8. PubMed ID: 12459007
    [Abstract] [Full Text] [Related]

  • 27. Selective muscarinic antagonists. II. Synthesis and antimuscarinic properties of biphenylylcarbamate derivatives.
    Naito R, Takeuchi M, Morihira K, Hayakawa M, Ikeda K, Shibanuma T, Isomura Y.
    Chem Pharm Bull (Tokyo); 1998 Aug 05; 46(8):1286-94. PubMed ID: 9734316
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor.
    Kozlowski JA, Lowe DB, Guzik HS, Zhou G, Ruperto VB, Duffy RA, McQuade R, Crosby G, Taylor LA, Billard W, Binch H, Lachowicz JE.
    Bioorg Med Chem Lett; 2000 Oct 16; 10(20):2255-7. PubMed ID: 11055332
    [Abstract] [Full Text] [Related]

  • 30. Activation of M2 muscarinic receptors in guinea-pig ileum opens cationic channels modulated by M3 muscarinic receptors.
    Bolton TB, Zholos AV.
    Life Sci; 1997 Oct 16; 60(13-14):1121-8. PubMed ID: 9121356
    [Abstract] [Full Text] [Related]

  • 31. A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.
    Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M.
    Bioorg Med Chem Lett; 2002 Sep 16; 12(18):2535-9. PubMed ID: 12182854
    [Abstract] [Full Text] [Related]

  • 32. Muscarinic M3 receptor inactivation reveals a pertussis toxin-sensitive contractile response in the guinea pig colon: evidence for M2/M3 receptor interactions.
    Sawyer GW, Ehlert FJ.
    J Pharmacol Exp Ther; 1999 Apr 16; 289(1):464-76. PubMed ID: 10087039
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
    Naito R, Yonetoku Y, Okamoto Y, Toyoshima A, Ikeda K, Takeuchi M.
    J Med Chem; 2005 Oct 20; 48(21):6597-606. PubMed ID: 16220976
    [Abstract] [Full Text] [Related]

  • 34. Characterization of the interaction of zamifenacin at muscarinic receptors in vitro.
    Watson N, Reddy H, Stefanich E, Eglen RM.
    Eur J Pharmacol; 1995 Oct 16; 285(2):135-42. PubMed ID: 8566131
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF, Davids JH, Elzinga CR, Wolf D, Zaagsma J, Kilbinger H.
    Br J Pharmacol; 1997 Sep 16; 122(1):133-41. PubMed ID: 9298539
    [Abstract] [Full Text] [Related]

  • 36. Selectivity profile of some recent muscarinic antagonists in bovine and guinea-pig trachea and heart.
    Roffel AF, Hamstra JJ, Elzinga CR, Zaagsma J.
    Arch Int Pharmacodyn Ther; 1994 Sep 16; 328(1):82-98. PubMed ID: 7893193
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and muscarinic M2 subtype antagonistic activity of unnatural ent-himbacine and an enantiomeric pair of (2'S,6'R)-diepihimbacine.
    Takadoi M, Terashima S.
    Bioorg Med Chem Lett; 2002 Oct 21; 12(20):2871-3. PubMed ID: 12270166
    [Abstract] [Full Text] [Related]

  • 38. Muscarinic M2 receptor-mediated contraction in the guinea pig Taenia caeci: possible involvement of protein kinase C.
    Shen A, Mitchelson F.
    Biochem Pharmacol; 1998 Dec 01; 56(11):1529-37. PubMed ID: 9827588
    [Abstract] [Full Text] [Related]

  • 39. In vitro characterization of a novel, potent and selective M3 antagonist.
    Ghelardini C, Bartolini A, Galeotti N, Bellucci C, Dei S, Gualtieri F.
    Life Sci; 1997 Dec 01; 61(13):1217-26. PubMed ID: 9324063
    [Abstract] [Full Text] [Related]

  • 40. Quinuclidin-2-ene-based muscarinic antagonists.
    Hacksell U, Nilsson BM, Nordvall G, Johansson G, Sundquist S, Nilvebrant L.
    Life Sci; 1995 Dec 01; 56(11-12):831-6. PubMed ID: 10188782
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.